GYG1P3

Across TCGA pan-cancer cohorts, GYG1P3 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of GYG1P3’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where GYG1P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GYG1P3 is over-expressed in tumor, although a few such as LUSC and READ show the opposite, repressed pattern.

KIRP, LUSC, and READ are the cancer types where GYG1P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GYG1P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	Female	II,III,IV	+0.054	.003	3	view →
LUSC	Male	III,IV	−0.060	.030	2	view →
READ	All	All	−0.048	.028	2	view →
ESCA	Female	All	−0.123	.009	1	view →
LIHC	All	II,III,IV	−0.009	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

GYG1P3–KIRP

Open the KIRP breakdown →